Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy
Authors:
- Preston S. FoxPFPreston S. Fox
- Christopher J. BergCBChristopher J. Berg
- John F. CardellaJCJohn F. Cardella
- Thomas M. KrummelTKThomas M. Krummel
- 31 October 1993
- journal article
- case report
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 28 (10) , 1264-1269
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Investigational Use of Tissue Plasminogen Activator (t‐PA) for Occluded Central Venous CathetersJournal of Parenteral and Enteral Nutrition, 1990
- Successful treatment of neonatal aortic thrombosis with tissue plasminogen activatorThe Journal of Pediatrics, 1990
- Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvisThrombosis Research, 1989
- Streptokinase for aortic thrombosis.Archives of Disease in Childhood, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJACC, 1988
- Treatment of Grafts and Major Vessel Thrombosis with Low-Dose Streptokinase in ChildrenThe Annals of Thoracic Surgery, 1986
- Low-dose fibrinolytic therapy in infantsThe Journal of Pediatrics, 1985
- Thrombolytic TherapyNew England Journal of Medicine, 1982